Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes

Deborah E. Sellmeyer, Roberto Civitelli, Lorenz C. Hofbauer, Sundeep Khosla, Beata Lecka-Czernik, Ann V. Schwartz

Research output: Contribution to journalReview article

55 Scopus citations

Abstract

Fracture risk is significantly increased in both type 1 and type 2 diabetes, and individuals with diabetes experience worse fracture outcomes than normoglycemic individuals. Factors that increase fracture risk include lower bone mass in type 1 diabetes and compromised skeletal quality and strength despite preserved bone density in type 2 diabetes, as well as the effects of comorbidities such as diabetic macro- and microvascular complications. In this Perspective, we assess the developing scientific knowledge regarding the epidemiology and pathophysiology of skeletal fragility in patients with diabetes and the emerging data on the prediction, treatment, and outcomes of fractures in individuals with type 1 and type 2 diabetes.

Original languageEnglish (US)
Pages (from-to)1757-1766
Number of pages10
JournalDiabetes
Volume65
Issue number7
DOIs
StatePublished - Jul 1 2016

    Fingerprint

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Sellmeyer, D. E., Civitelli, R., Hofbauer, L. C., Khosla, S., Lecka-Czernik, B., & Schwartz, A. V. (2016). Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes. Diabetes, 65(7), 1757-1766. https://doi.org/10.2337/db16-0063